tiprankstipranks
Advertisement
Advertisement
ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year
PremiumThe FlyProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year
2M ago
ProMIS Neurosciences: Strengthened Balance Sheet and Differentiated PMN310 Alzheimer’s Program Underpin Buy Rating
Premium
Ratings
ProMIS Neurosciences: Strengthened Balance Sheet and Differentiated PMN310 Alzheimer’s Program Underpin Buy Rating
3M ago
ProMIS Neurosciences files $200M mixed securities shelf
Premium
The Fly
ProMIS Neurosciences files $200M mixed securities shelf
3M ago
ProMIS Neurosciences exceeds target enrollment in PRECISE-AD
PremiumThe FlyProMIS Neurosciences exceeds target enrollment in PRECISE-AD
7M ago
ProMIS Neurosciences Regains Nasdaq Compliance
Premium
Company Announcements
ProMIS Neurosciences Regains Nasdaq Compliance
7M ago
ProMIS Neurosciences announces publication highlighting PMN310
Premium
The Fly
ProMIS Neurosciences announces publication highlighting PMN310
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100